Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell Disease
Kaiqi Sun(The University of Texas Health Science Center at Houston), Yang Xia(Northcentral University), Julie A. Reisz(University of Colorado Anschutz Medical Campus), Vladimír Berka(The University of Texas Health Science Center at Houston), Aji Huang(The University of Texas Health Science Center at Houston), Martin K. Safo(Virginia Commonwealth University), Y. Edward Wen(The University of Texas Health Science Center at Houston), Mikhail Bogdanov(The University of Texas Health Science Center), Ah‐Lim Tsai(The University of Texas Health Science Center at Houston), Alexander Wen(The University of Texas Health Science Center at Houston), Travis Nemkov(University of Colorado Anschutz Medical Campus), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), Leng Han(Indiana University Health), Zhangzhe Peng(Central South University), Mostafa H. Ahmed(Virginia Commonwealth University), Osheiza Abdulmalik(Children's Hospital of Philadelphia), Tzu‐Ping Ko(Institute of Biological Chemistry, Academia Sinica), Kirk C. Hansen(University of Colorado Anschutz Medical Campus), Morayo G. Adebiyi(The University of Texas Health Science Center at Houston), Anren Song(The University of Texas Health Science Center), Modupe Idowu(The University of Texas Health Science Center at Houston), Hongyu Wu(The University of Texas Health Science Center at Houston), Hong Liu(Zhejiang Chinese Medical University), Yujin Zhang, Jing Gong(Hunan University of Traditional Chinese Medicine), William Dowhan(The University of Texas Health Science Center), Harinder S. Juneja(The University of Texas Health Science Center at Houston), Rodney E. Kellems(Baylor College of Medicine)
Cited by 65
Related Papers
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
|JCI Insight|2020|600
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
|Cancer Cell|2018|565
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
|Proceedings of the National Academy of Sciences|2018|556
Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia
|Cancer Discovery|2020|550
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
|Cell Reports|2018|526